Skip to content
Search

Latest Stories

Coeliac UK raises ‘grave concerns’ over withdrawal of gluten free prescriptions in West Yorkshire

Coeliac UK raises ‘grave concerns’ over withdrawal of gluten free prescriptions in West Yorkshire

The charity has urged the ICB to reconsider their policy which poses an additional challenge for people living with the condition

NHS West Yorkshire Integrated Care Board (ICB)’s decision to withdraw gluten free prescriptions for people with coeliac disease across Leeds and Calderdale has disappointed Coeliac UK.


In a statement released on Thursday, the charity, which provides support and advice to those living with the disease, has raised “grave concerns” about the decision, warning that it will have a detrimental impact on the coeliac community.

The policy is currently implemented across the ICB’s other places including Bradford district and Craven, Kirklees and Wakefield district, preventing coeliac patients from accessing gluten free bread and flour mix on prescription.

NHS West Yorkshire ICB wants to align its gluten free prescribing guidelines across its five places.

But the charity is worried that the additional cost of gluten free staple products will poses a real challenge to maintaining the gluten-free diet, which is the only treatment for the condition.

A study by the charity last year found that a weekly gluten free food shop can be 20 per cent more expensive than a standard weekly food shop. Further, the report revealed that the cheapest loaf of gluten free bread cost 7.2 times more than the cheapest gluten containing loaf.

Tristan Humphreys, Head of Advocacy, Coeliac UK, said: “We are extremely disappointed that NHS West Yorkshire ICB has taken this decision. These changes remove a much-needed lifeline for those with coeliac disease in Leeds and Calderdale at a time when the cost-of-living crisis is hitting people with coeliac disease particularly hard.

“Failure to support people with coeliac disease risks them developing serious long-term conditions down the line, the cost of which overshadows that of gluten free prescriptions,” he added.

According to Humphreys, the ICB has failed to provide any evidence to support their claims that there has not been any adverse impact on the places that previously withdrew gluten free prescribing.

Hence, Coeliac UK has urged the ICB to reconsider this policy and “do the right thing, based on the evidence.”

The charity suggested that West Yorkshire should follow the footsteps of neighbouring NHS South Yorkshire ICB which has adopted a policy of gluten free prescribing for health equality grounds.

Sue Johnson

Picture: Sue Johnson

The withdrawal of gluten free prescriptions has come as a big blow to Sue Johnson, a coeliac patient from Leeds, who is already struggling to secure gluten free food due to inflation.

She said: “I was diagnosed with coeliac disease when I was in my forties and I shall be 77 this year. If I consume gluten I have very severe symptoms. Within an hour, I feel faint and dizzy and need to lie down. Following that, I'm repeatedly violently sick and experience bouts of diarrhoea, alongside painful cramps which can last for days.

“I have struggled to pay my gas and electricity bills over the last year, all made worse by higher food prices. This will only get more difficult, without access to gluten free bread and flour on prescription.

“Gluten free food is my medicine. I feel really let down by the ICB, who don’t seem to understand the reality for people living with coeliac disease,” she added.

While patients can opt for gluten free substitute foods such rice and potatoes, there are practical challenges for food on the go, packed lunches, additional preparation requirements and energy costs for cooking, the charity noted.

Coeliac disease is an autoimmune disorder in which the immune system mistakenly recognizes gluten (a protein found in wheat, barley, and rye) as "foreign" and causes chronic inflammation in the small intestine, and lead to bloating, stomach cramps, vomiting, diarrhoea and tiredness.

Patients are also at risk of developing osteoporosis, neurological dysfunction, unexplained infertility, recurrent miscarriage and in rare cases even small bowel cancer.

 

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less